Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Daily News

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

Michael O'Riordan

April 27, 2023

News Daily News

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

L.A. McKeown

September 22, 2021

News Daily News

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

Caitlin E. Cox

October 12, 2020

News Daily News

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Shelley Wood

February 19, 2019

News Daily News

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Todd Neale

January 17, 2018

News Daily News

Prosthesis-Patient Mismatch After Aortic Valve Replacement Declining but Tied to Poorer Survival

Todd Neale

January 25, 2017

News Daily News

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

L.A. McKeown

June 17, 2015

News Daily News

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

Yael L. Maxwell

February 02, 2015

News Daily News

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

Yael L. Maxwell

October 10, 2014

News Daily News

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

October 03, 2014

News Daily News

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

July 10, 2014

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Daily News

Patient-Prosthesis Mismatch May Diminish Transcatheter Valve Benefit

October 05, 2011

Advertisement

TAVI Explantation Remains a Risky Proposition, Two New Studies Show

EXPLANT-TAVR: Data Spur Conversation About Balancing Risk and Lifetime Management

PARTNER Data Back 5-Year Durability of Sapien 3 TAVR

New Leaflet Thrombosis After TAVR Seen Out to 3 Years: OCEAN-TAVI

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Prosthesis-Patient Mismatch After Aortic Valve Replacement Declining but Tied to Poorer Survival

Lotus Valve Tops CoreValve on Some Measures in Single-Center, Nonrandomized Study

Most Late Cardiac Mortality After TAVR Due to Heart Failure, Sudden Cardiac Death

PARTNER Subanalysis Examines Effect of Annulus Size on Valve Hemodynamics, Outcomes

More Prosthesis-Patient Mismatch with Surgery vs TAVR, Linked to Worse Outcomes

VIVID Registry: Benefit of Valve-in-Valve TAVR Depends on Size, Status of Failed Surgical Bioprosthesis

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Patient-Prosthesis Mismatch May Diminish Transcatheter Valve Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content